The UK-based healthtech company Doctor Care Anywhere lodged a prospectus on 30 October to undertake an initial public offering (IPO) in the Australian capital market on 4 December.
The company aims to raise $102 million with an issue price of $0.80 per share. This is upsized from the company’s original plans to raise $75 million.
Doctor Care Anywhere advises that the majority of the funds raised by the IPO will be used to support investments in marketing and engagement functions, investment in new products and building international business development capabilities.
What is Doctor Care Anywhere?
Doctor Care Anywhere is a London-based telehealth company founded by Doctor Bayu Thakar, a qualified medical doctor and a McKinsey alumnus.
The company’s business model is to recruit its own clinicians to provide patients with virtual GP consultations in the form of video or phone consultations with GPs who are directly employed by Doctor Care Anywhere. It also provides diagnostic referrals and specialist reviews across the key clinical specialties.
The company has grown rapidly since its inception in 2014, providing services to more than 1,500 corporate and SME clients through its major channel relationships.
The digital health market
The global telehealth market was estimated to be $7.30 billion in 2019 and is forecast to reach $20.50 billion in 2024, growing at a compound annual growth rate of 23.10%.
Doctor Care Anywhere currently focuses on the UK private healthcare market but advises it is looking to accelerate its business expansion to capture this growing telehealth market.
According to its prospectus, Doctor Care Anywhere has chosen to list in Australia because it is a developed market with investors who understand healthtech and are keen to invest in digital healthcare.
Doctor Care Anywhere chair Jonathan Baines said:
The impact of COVID-19 on all our lives has demonstrated the vital role that technology can and must play in the future of healthcare. We see DOC at the forefront of this revolution and we have a clear and ambitious growth strategy that aims to create real value for investors in the rapidly growing digital health market.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
More reading
- ASX stock of the day: Redbubble (ASX:RBL) shares up 5% today
- Top brokers name 3 ASX shares to buy today
- Why ASX tech shares should fly long after this crisis is over
- Morgan Stanley updates its share price targets for the big 4 banks
- Why Aristocrat Leisure, Chalice Gold, Westpac, & Whitehaven Coal shares are charging higher
Motley Fool contributor Miles Wu has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post UK’s Doctor Care Anywhere to dial in to ASX telehealth ranks appeared first on Motley Fool Australia.
from Motley Fool Australia https://ift.tt/32UbZ9P
Leave a Reply